December 6, 2024

Clinical Trials Rally

News & Updates

PHENTrials.com Enhanced

Makes Clinical Trials Available to All Prostate Cancer Patients

PHENTrials.com now allows prostate cancer patients to identify clinical trials for their specific diagnosis anywhere in the United States.

Clinical trials provide treatments that can be lifesaving and may be the only options for patients with certain diagnoses. Identifying and understanding clinical trials can be complicated and a mystery for most patients; however, PHENTrials.com solves this.

PHENTrials.com has a database of all actively recruiting prostate cancer clinical trials for the different diagnoses (see right)

Prostate Cancer Diagnoses

Using the "Find-Your-Trial (FYT)" search tool, patients can enter their diagnosis and the state where they live. Information on all the appropriate trials will be displayed. Patients can review this information and have informed discussions with the trial investigators and their doctors.

This expanded capability aims to increase clinical trial knowledge and participation of Black patients, who are underrepresented in trials, and other patients who have not been able to take advantage of the benefits offered by clinical trials.

Visit PHENTrials.com

Managing Survivorship Special Meeting

December 11, 2024

6:00 PM

This month's Managing Survivorship Meeting will consist of a demonstration of the enhanced PHENTrials.com by Dr. Keith Crawford, PHEN's Director of Clinical Trials and Patient Education. Dr. Crawford will explain and demonstrate how these updates in the FYT tool can help you identify advanced prostate cancer treatment options that are only available in clinical trials. Dr. Crawford will answer your questions, and you will leave this meeting able to easily find the most appropriate trials for you based on your needs and where you live.

If you want to attend this meeting in person, it will be held at the Dana-Farber Cancer Institute in Boston. The address is 450 Brookline Ave (Jimmy Fund Way), Third Floor, Yawkey 308, Room 305 G ADM (free parking and refreshments for in-person attendees)

A Patient's Clinical Trial Journey

"Clinical trials were not introduced when I was first diagnosed with prostate cancer in 2004. As a PHEN survivor network member, I began learning more about clinical research over the last five years.”

- Mr. Sherman Womack

Mr. Womack underwent surgery in February of 2005, followed by radiation treatment. For more than 15 years, he has been treated at Massachusetts General Hospital, receiving additional treatments of chemotherapy and Androgen Deprivation Therapy (ADT). His oncologist wanted him to start a clinical trial when the chemotherapy stopped working.

He was able to begin the clinical trial in 2022. The trial involved six treatments, and Mr. Womack explained that the investigators and staff were very helpful, as he received numerous phone calls from them checking in on him. This trial proved to be highly successful and involved very minimal side effects. Mr. Womack's experience highlights how clinical trials can be effective treatments. Watch Video

Clinical Trial Highlights - Patient Summaries

AMG - 509 (Amgen)

This clinical trial is for patients who have metastatic castration resistant prostate cancer (mCRPC) and failed to respond to abiraterone acetate or enzalutamide (but not both) and to taxane-based chemotherapy.

View Summary

Omaha - 004 (Merck)

This clinical trial is for participants who have metastatic castration-resistant prostate cancer (mCRPC) and whose cancer progressed on or after they were previously treated with next-generation Hormonal Agent (NHA).

View Summary

View More Patient Summaries